---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-23-012033"
form_type: "8-K"
ticker: null
cik: "0000887247"
company_name: "DMK PHARMACEUTICALS Corp"
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T03:07:37.663835+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# DMK Pharmaceuticals receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Received Nasdaq notice on Oct 4, 2023 for failing $1.00 minimum bid price (Rule 5550(a)(2)).
- 180-day compliance period until April 1, 2024; must close at $1.00+ for 10 consecutive days.
- If not cured, may be eligible for an additional 180-day period if other listing standards are met.
- Company will monitor bid price and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001387131-23-012033
- form_type: 8-K
- cik: 0000887247
- company_name: DMK PHARMACEUTICALS Corp
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887247/000138713123012033/0001387131-23-012033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887247/000138713123012033/dmk-8k_100423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-23-012033
- JSON: https://secwatch.observer/filing/0001387131-23-012033.json
- Plain text: https://secwatch.observer/filing/0001387131-23-012033.txt

## Key facts
- Listing & Compliance Notices
  DMK PHARMACEUTICALS Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: armaceuticals Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the $1.00 minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on The Nasdaq Capital Market. Based on the closing bid price of the Company’s common stock for at least 30 consecutive business days before receipt of the Notice, the Company no longer meets the minimum bid price requirement of the Rule. This notice has
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000138713123012033/0001387131-23-012033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.